Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Get an expert’s take on recent advances and current best practices in the use of immune checkpoint inhibitors for treating gastroesophageal cancers in this program that includes live workshops, an on-demand Webcast, and downloadable slideset.
Manish A. Shah, MD
Zev A. Wainberg, MD

Downloadable Slideset

Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with gastroesophageal cancers.

Manish A. Shah, MD Zev A. Wainberg, MD Released: August 10, 2020

Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with gastroesophageal cancers.

Manish A. Shah, MD Zev A. Wainberg, MD Released: August 10, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue